Figure 2From: A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHDMean Investigator rated ADHD-RS Score (ITT Population) for (a) all Subjects, (b) the ADHD Inattentive Subgroup and (c) the ADHD Combined Subgroup. Active treatment is given week 0 to 8, where week twelve is a follow-up visit.Back to article page